Patents by Inventor John M. Weaver

John M. Weaver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4461772
    Abstract: At least one compound defined by one of the following formulae: ##STR1## where X represents Cl, Br, ##STR2## NHSO.sub.2 CH.sub.3, ##STR3## or --SCH.sub.3, and n is 1 or 2; andCH.sub.3 SO.sub.2 NHCH.sub.2 CH.sub.2 CN (II)have been administered to animals to improve the efficiency of food utilization by these animals. These compounds can be administered orally by combining the compounds with feed compositions and fed to animals such as ruminants with a developed rumen function as well as other animals that ferment fibrous material and vegetable matter in the cecum or colon. These compounds effect the rumen metabolism to increase the production of propionate relative to other volatile fatty acids, particularly acetate and to inhibit methanogenesis.
    Type: Grant
    Filed: March 21, 1983
    Date of Patent: July 24, 1984
    Assignee: SDS Biotech Corporation
    Inventors: Paul E. Marecki, John M. Weaver
  • Patent number: 4425325
    Abstract: The astringency of an oral composition containing biologically active zinc ions may be reduced by the addition of glycine to the composition, and adjustment of the pH to about 4.5 to 9.4. In addition, zinc may be kept in a biologically active solution at this pH by the addition of glycine. The zinc-glycine combination serves as an anticalculus-antiplaque-antimalodor agent in oral compositions.
    Type: Grant
    Filed: February 3, 1982
    Date of Patent: January 10, 1984
    Assignee: Lever Brothers Company
    Inventors: Thomas W. Ritchey, John M. Weaver, Martin Sapone
  • Patent number: 4423224
    Abstract: At least one compound defined by one of the following formulae: ##STR1## where X represents Cl, Br, ##STR2## or--SCH.sub.3, and n is 1 or 2; andCH.sub.3 SO.sub.2 NHCH.sub.2 CH.sub.2 CN (II)have been administered to animals to improve the efficiency of food utilization by these animals. These compounds can be administered orally by combining the compounds with feed compositions and fed to animals such as ruminants with a developed rumen function as well as other animals that ferment fibrous material and vegetable matter in the cecum or colon. These compounds effect the rumen metabolism to increase the production of propionate relative to other volatile fatty acids, particularly acetate and to inhibit methanogenesis.
    Type: Grant
    Filed: September 8, 1980
    Date of Patent: December 27, 1983
    Assignee: SDS Biotech Corporation
    Inventors: Paul E. Marecki, John M. Weaver
  • Patent number: 4416867
    Abstract: The astringency of an oral composition containing biologically active zinc ions may be reduced by the addition of glycine to the composition, and adjustment of the pH to 4.5 to 8. In addition, zinc ions may be kept in a biologically active solution at this pH by the addition of glycine. The zinc-glycine combination serves as an anticalculus-antiplaque agent in oral compositions.
    Type: Grant
    Filed: February 10, 1982
    Date of Patent: November 22, 1983
    Assignee: Lever Brothers Company
    Inventors: Thomas W. Ritchey, John M. Weaver, Martin Sapone
  • Patent number: 4339432
    Abstract: The astringency of an oral mouthwash composition containing biologically active zinc ions may be reduced by the addition of glycine to the composition, and adjustment of the pH to 4.5 to 8. In addition, zinc ions may be kept in a biologically active solution at this pH by the addition of glycine. The zinc-glycine combination serves as an anticalculus-antiplaque agent in oral compositions.
    Type: Grant
    Filed: February 17, 1981
    Date of Patent: July 13, 1982
    Assignee: Lever Brothers Company
    Inventors: Thomas W. Ritchey, John M. Weaver, Martin Sapone